59237Toplam
0Olumlu
0Olumsuz
50Nötr
Piyasa:
Tümü
🇹🇷 BIST
Kripto
🇺🇸 ABD
🇰🇿 KASE
🇪🇬 EGX
🇸🇾 DSE
🇸🇦 Tadawul
🇦🇪 DFM
🇶🇦 QSE
🇷🇺 MOEX
🇬🇧 LSE
🇩🇪 Xetra
🇪🇺 Euronext
🇸🇪 Nordic
🇲🇦 CSE
🇯🇴 ASE
BRVM
🇮🇳 India
🇭🇰 HKEX
🇰🇷 KRX
🇿🇦 JSE
🇦🇺 ASX
🇧🇷 B3
🇹🇼 TWSE
🇸🇬 SGX
🇨🇳 China
🇯🇵 Japan
Sayfa 119 / 1185 · toplam 59237 haber
—
3 Must-Know COLA Facts Before the Big Announcement
Bu özet yapay zekâ ile otomatik üretildi
Social Security's cost-of-living adjustment (COLA) for 2027 is expected to be announced Oct.
—
Russia stocks lower at close of trade; MOEX Russia Index unchanged
Bu özet yapay zekâ ile otomatik üretildi
Russia stocks lower at close of trade; MOEX Russia Index unchanged
—
Prosperity Bancshares director Ned Holmes sells $72,363 in stock
Bu özet yapay zekâ ile otomatik üretildi
Prosperity Bancshares director Ned Holmes sells $72,363 in stock
—
SailPoint chief accounting officer Mitra Rezvan sells $23,360 in stock
Bu özet yapay zekâ ile otomatik üretildi
SailPoint chief accounting officer Mitra Rezvan sells $23,360 in stock
—
VOO Doesn't Hold SpaceX, Taiwan Semiconductor, Samsung Electronics, SK Hynix, or ASML. Meet the Vanguard ETF That Does.
Bu özet yapay zekâ ile otomatik üretildi
Some of the world's most important artificial intelligence (AI) stocks are noticeably absent from the S&P 500.
—
Infosys sees no material impact from U.S. PERM suspension
Bu özet yapay zekâ ile otomatik üretildi
Infosys sees no material impact from U.S. PERM suspension
—
The Stock Market Will Look Completely Different by 2030. This Is the Stock I'm Buying Before It Does.
Bu özet yapay zekâ ile otomatik üretildi
Nvidia is primed to benefit from the massive ongoing AI build-out.
—
SA Asks: Is now the time to buy quantum stocks? If so, which ones?
Bu özet yapay zekâ ile otomatik üretildi
SA Asks: Is now the time to buy quantum stocks? If so, which ones?
—
Nvidia in talks to invest further in Reflection AI or buy it, FT reports
Bu özet yapay zekâ ile otomatik üretildi
Nvidia in talks to invest further in Reflection AI or buy it, FT reports
—
Pacira BioSciences SVP Lauren Riker sells $217,920 in stock
Bu özet yapay zekâ ile otomatik üretildi
Pacira BioSciences SVP Lauren Riker sells $217,920 in stock
—
Redwire vs. Rocket Lab: Which Industrials Stock Is a Better Buy in 2026?
Bu özet yapay zekâ ile otomatik üretildi
Both companies are unprofitable and burning cash, but their paths to scale, and valuations, tell strikingly different stories.
—
Zymeworks EVP Adam Schayowitz sells $357,557 in ZYME stock for taxes
Bu özet yapay zekâ ile otomatik üretildi
Zymeworks EVP Adam Schayowitz sells $357,557 in ZYME stock for taxes
—
Key deals this week: Option Care Health, PTC, Energy Transfer and more
Bu özet yapay zekâ ile otomatik üretildi
Key deals this week: Option Care Health, PTC, Energy Transfer and more
—
Russia Lifts Ban on Diesel Exports as Part of Trump-Putin Deal - Bloomberg.com
Bu özet yapay zekâ ile otomatik üretildi
Russia Lifts Ban on Diesel Exports as Part of Trump-Putin Deal Bloomberg.com
—
Better Biotechnology ETF: First Trust FBT vs. VanEck BBH
Bu özet yapay zekâ ile otomatik üretildi
VanEck's lower 0.35% expense ratio appeals to cost-conscious investors, while First Trust's $2.9 billion in assets and equal-weighted approach offer broader diversification across 30 biotech holdings.
—
Could $1,000 Invested in Bitcoin Help You Retire a Millionaire?
Bu özet yapay zekâ ile otomatik üretildi
At one time, Bitcoin had 1,000x upside potential.
—
CEO Tom Ward Acquires 172,000 Mach Natural Resources Units for $2.0 Million. Is the Oil Boom a Gusher for the Stock?
Bu özet yapay zekâ ile otomatik üretildi
Ward's purchase through his revocable trust brings his aggregate stake to 28.4 million units, representing a 17.0% ownership interest in the energy partnership.
—
SkyAI 10% owner Bastion Trading buys $78,262 in SKYA stock
Bu özet yapay zekâ ile otomatik üretildi
SkyAI 10% owner Bastion Trading buys $78,262 in SKYA stock
—
Coupang vs. MercadoLibre: Which Consumer Stock Is a Better Buy in 2026?
Bu özet yapay zekâ ile otomatik üretildi
Coupang trades at a fraction of MercadoLibre's sales multiple, but the Latin American fintech giant generates far superior margins and cash flow.
—
Appian CEO Matthew Calkins sells $1.69m in company stock
Bu özet yapay zekâ ile otomatik üretildi
Appian CEO Matthew Calkins sells $1.69m in company stock
—
Silver ETF Faceoff: Will SLV or SIL Give You Better Exposure to the Shiny Metal?
Bu özet yapay zekâ ile otomatik üretildi
iShares Silver Trust offers lower fees and $30.5B in assets, while Global X Silver Miners ETF delivers dividend income and operational leverage from mining companies.
—
China passenger vehicle retail market slumps 24% in September
Bu özet yapay zekâ ile otomatik üretildi
China passenger vehicle retail market slumps 24% in September
—
Infosys, ABD PERM askıya alınmasından maddi etki beklemiyor
Bu özet yapay zekâ ile otomatik üretildi
Infosys, ABD PERM askıya alınmasının işe alım ve gelir üzerinde maddi etkisi olmayacağını belirtti.
—
Banco Bradesco's Head of PE and VC Purchases $1.7 Million Shares. Does This Signal the Brazilian Bank Is a Buy?
Bu özet yapay zekâ ile otomatik üretildi
Roberto De Jesus Paris expanded his direct stake by 36%, signaling confidence in the Brazilian bank's equity despite a modest one-year return.
—
CrowdStrike vs. UiPath: Which Technology Stock Is a Better Buy in 2026?
Bu özet yapay zekâ ile otomatik üretildi
CrowdStrike trades at a steep premium despite ongoing profitability challenges, while UiPath has just turned profitable with a valuation multiple a fraction of its rival's.
—
Everpure director Mallun Yen sells $1.75m in shares
Bu özet yapay zekâ ile otomatik üretildi
Everpure director Mallun Yen sells $1.75m in shares
—
Rapport Therapeutics CEO Abraham Ceesay sells $143,272 in stock
Bu özet yapay zekâ ile otomatik üretildi
Rapport Therapeutics CEO Abraham Ceesay sells $143,272 in stock
—
Pacific Biosciences CFO reports $2.05m stock sale
Bu özet yapay zekâ ile otomatik üretildi
Pacific Biosciences CFO reports $2.05m stock sale
—
1 Reason the Meta Muse AI Agent Has the Upper Hand
Bu özet yapay zekâ ile otomatik üretildi
Investors should be thinking about monetization strategies.
—
Here's What History Says October Will Bring for Nike Stock
Bu özet yapay zekâ ile otomatik üretildi
Shares have moved lower by 3% so far this month.
—
Here's the 1 Thing I'd Wait to See Before Buying SpaceX Stock.
Bu özet yapay zekâ ile otomatik üretildi
SpaceX must prove its AI spending is worth the near-term pain.
—
Analog devices director Ray Stata sells $1.17 million in shares
Bu özet yapay zekâ ile otomatik üretildi
Analog devices director Ray Stata sells $1.17 million in shares
—
Pimco high income fund director David Flattum buys $249,245 stock
Bu özet yapay zekâ ile otomatik üretildi
Pimco high income fund director David Flattum buys $249,245 stock
—
Pimco Dynamic Income Fund director David Flattum buys $249,508 in shares
Bu özet yapay zekâ ile otomatik üretildi
Pimco Dynamic Income Fund director David Flattum buys $249,508 in shares
—
EU-China trade relations hit crunch time as Brussels pushes for rebalancing
Bu özet yapay zekâ ile otomatik üretildi
EU-China trade relations hit crunch time as Brussels pushes for rebalancing
—
Joby Just Flew an Aircraft Across the United States With No Pilot. Here's Why Wall Street Shrugged.
Bu özet yapay zekâ ile otomatik üretildi
Joby's technology impressed, but Wall Street is waiting for revenue.
—
Advanced Micro Devices vs. Qualcomm: Which Technology Stock Is a Better Buy in 2026?
Bu özet yapay zekâ ile otomatik üretildi
AMD's net margin doubled while Qualcomm trades at a fraction of its rival's valuation, but customer concentration and competitive threats complicate both bets.
—
Mueller Water Products director Healy buys $29,927 in shares
Bu özet yapay zekâ ile otomatik üretildi
Mueller Water Products director Healy buys $29,927 in shares
—
Better Healthcare ETF: VanEck's Biotech-Focused BBH vs. State Street's XPH Targeting Pharma
Bu özet yapay zekâ ile otomatik üretildi
BBH concentrates on 25 large-cap biotech leaders, while XPH diversifies across 62 pharmaceutical holdings.
—
Philips investors’ move to probe company over 2021 recall denied by Dutch court
Bu özet yapay zekâ ile otomatik üretildi
Philips investors’ move to probe company over 2021 recall denied by Dutch court
—
Bristol Myers Squibb vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?
Bu özet yapay zekâ ile otomatik üretildi
Bristol Myers Squibb trades at a steeper discount despite higher leverage, while Novo Nordisk commands a premium on exceptional profitability and GLP-1 dominance.
—
AST SpaceMobile Has $3.7 Billion in Liquidity and No Commercial Revenue. Here's How to Value That.
Bu özet yapay zekâ ile otomatik üretildi
The LEO satellite developer still has plenty of upside potential.
—
908 devices CFO Joseph Griffith sells $65,150 in common stock
Bu özet yapay zekâ ile otomatik üretildi
908 devices CFO Joseph Griffith sells $65,150 in common stock
—
Expectations of Another Fed Rate Hike This Month Are Shifting Dramatically
Bu özet yapay zekâ ile otomatik üretildi
Suddenly, it appears the Fed may hit pause on rate hikes in October.
—
Cathie Wood Just Cut Her SpaceX Position. Is It Time to Sell?
Bu özet yapay zekâ ile otomatik üretildi
Cathie Wood loves SpaceX, but her firm sold some of its shares this week.
—
History Says This Is the 1 Portfolio Move Every Investor Should Make Before the Next Bear Market
Bu özet yapay zekâ ile otomatik üretildi
Diversification is still one of the best strategies for long-term investing.
—
Prediction: This Is What a $5,000 Investment in the Vanguard S&P 500 ETF (VOO) Will Be Worth by 2040
Bu özet yapay zekâ ile otomatik üretildi
How does $19,000 sound?
—
Saba Capital Management sells $355,376 in BlackRock ESG trust
Bu özet yapay zekâ ile otomatik üretildi
Saba Capital Management sells $355,376 in BlackRock ESG trust
—
Here's What a $10,000 Investment in Broadcom Stock Could Be Worth in 5 Years. (Hint: It Could Be 1 of the Best AI Stocks to Buy Today.)
Bu özet yapay zekâ ile otomatik üretildi
Broadcom stock has the potential to triple in value in the next five years.
—
A Battle of REIT ETFs: Which REIT ETF Offers Better Value for Income-Oriented Investors?
Bu özet yapay zekâ ile otomatik üretildi
State Street's fund charges just 0.08% annually versus iShares' 0.32%, but performance and yield tell a more nuanced story.
Sayfa 119 / 1185 · toplam 59237 haber